🔎 Trials Near Me

Home › Urogenital Cancer › North Carolina

Pag-aaral pangklinika para sa Urogenital Cancer sa North Carolina

6 pag-aaral para sa Urogenital Cancer ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study

  • FirstHealth of the Carolinas-Moore Regional Hospital, Pinehurst
  • Wake Forest NCORP Research Base, Winston-Salem
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07215624

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill
  • Margaret R Pardee Memorial Hospital, Hendersonville
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT03866382

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

  • The University of North Carolina Chapel Hill, Chapel Hill
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05874921

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • Duke University Medical Center, Durham
Nagre-recruitPhase 1/2
Edad 18 pataas · Kalalakihan · Na-update Set 25, 2026 · NCT06800313

Discharge Medication Use Post-Operatively in GU Cancer Patients

  • Levine Cancer Institute, Charlotte
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT06795087

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • Duke Cancer Center, Durham
Nagre-recruitPhase 1
Edad 18 pataas · Kalalakihan · Na-update Hul 9, 2026 · NCT07103018

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.